Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

GSK, a British drugmaker, recently beat Q4 earnings estimates. The company is our FDI of the Month January 2025.

In a significant leadership transition announced today, Eicher Motors Limited (EML) has appointed Siddhartha Lal as its new ...

Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

Julie Kim, currently Takeda’s U.S. head, will replace Weber in June 2026 and become one of the few female CEOs of a top ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Insomniac Games founder and CEO Ted Price is stepping down from his role atop the Sony Interactive Entertainment-owned studio after more than 30 years running the company behind PlayStation‘s ...

Not by a little bit, by a lot," BofA Chairman and CEO Brian Moynihan said of America’s economic landscape during a "Mornings with Maria" interview from the World Economic Forum in Davos ...

Ontario Liberal MPP Adil Shamji said removing the Ontario Health atHome CEO was “long past due” but failed to address a deeper problem. “Home care should be the focus — not the footnote ...

According to the email, while the company looks for its next CEO, Stacie Herron, KE’s current chief legal and administrative officer will serve as interim chief operating officer. In a statement ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...